Copyright Reports & Markets. All rights reserved.

Global Tacrolimus Extended Release Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tacrolimus Extended Release Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.5mg
    • 1.3.3 1mg
    • 1.3.4 5mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tacrolimus Extended Release Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Tacrolimus Extended Release Capsules Market Size & Forecast
    • 1.5.1 Global Tacrolimus Extended Release Capsules Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Tacrolimus Extended Release Capsules Sales Quantity (2021-2032)
    • 1.5.3 Global Tacrolimus Extended Release Capsules Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Astellas pharma Europe B.V.
    • 2.1.1 Astellas pharma Europe B.V. Details
    • 2.1.2 Astellas pharma Europe B.V. Major Business
    • 2.1.3 Astellas pharma Europe B.V. Tacrolimus Extended Release Capsules Product and Services
    • 2.1.4 Astellas pharma Europe B.V. Tacrolimus Extended Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Astellas pharma Europe B.V. Recent Developments/Updates
  • 2.2 Mylan Pharmaceuticals
    • 2.2.1 Mylan Pharmaceuticals Details
    • 2.2.2 Mylan Pharmaceuticals Major Business
    • 2.2.3 Mylan Pharmaceuticals Tacrolimus Extended Release Capsules Product and Services
    • 2.2.4 Mylan Pharmaceuticals Tacrolimus Extended Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mylan Pharmaceuticals Recent Developments/Updates
  • 2.3 Sandoz
    • 2.3.1 Sandoz Details
    • 2.3.2 Sandoz Major Business
    • 2.3.3 Sandoz Tacrolimus Extended Release Capsules Product and Services
    • 2.3.4 Sandoz Tacrolimus Extended Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sandoz Recent Developments/Updates
  • 2.4 Accord Healthcare
    • 2.4.1 Accord Healthcare Details
    • 2.4.2 Accord Healthcare Major Business
    • 2.4.3 Accord Healthcare Tacrolimus Extended Release Capsules Product and Services
    • 2.4.4 Accord Healthcare Tacrolimus Extended Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Accord Healthcare Recent Developments/Updates

3 Competitive Environment: Tacrolimus Extended Release Capsules by Manufacturer

  • 3.1 Global Tacrolimus Extended Release Capsules Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Tacrolimus Extended Release Capsules Revenue by Manufacturer (2021-2026)
  • 3.3 Global Tacrolimus Extended Release Capsules Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Tacrolimus Extended Release Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Tacrolimus Extended Release Capsules Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Tacrolimus Extended Release Capsules Manufacturer Market Share in 2025
  • 3.5 Tacrolimus Extended Release Capsules Market: Overall Company Footprint Analysis
    • 3.5.1 Tacrolimus Extended Release Capsules Market: Region Footprint
    • 3.5.2 Tacrolimus Extended Release Capsules Market: Company Product Type Footprint
    • 3.5.3 Tacrolimus Extended Release Capsules Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tacrolimus Extended Release Capsules Market Size by Region
    • 4.1.1 Global Tacrolimus Extended Release Capsules Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Tacrolimus Extended Release Capsules Consumption Value by Region (2021-2032)
    • 4.1.3 Global Tacrolimus Extended Release Capsules Average Price by Region (2021-2032)
  • 4.2 North America Tacrolimus Extended Release Capsules Consumption Value (2021-2032)
  • 4.3 Europe Tacrolimus Extended Release Capsules Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Tacrolimus Extended Release Capsules Consumption Value (2021-2032)
  • 4.5 South America Tacrolimus Extended Release Capsules Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Tacrolimus Extended Release Capsules Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Tacrolimus Extended Release Capsules Sales Quantity by Type (2021-2032)
  • 5.2 Global Tacrolimus Extended Release Capsules Consumption Value by Type (2021-2032)
  • 5.3 Global Tacrolimus Extended Release Capsules Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Tacrolimus Extended Release Capsules Sales Quantity by Application (2021-2032)
  • 6.2 Global Tacrolimus Extended Release Capsules Consumption Value by Application (2021-2032)
  • 6.3 Global Tacrolimus Extended Release Capsules Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Tacrolimus Extended Release Capsules Sales Quantity by Type (2021-2032)
  • 7.2 North America Tacrolimus Extended Release Capsules Sales Quantity by Application (2021-2032)
  • 7.3 North America Tacrolimus Extended Release Capsules Market Size by Country
    • 7.3.1 North America Tacrolimus Extended Release Capsules Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Tacrolimus Extended Release Capsules Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Tacrolimus Extended Release Capsules Sales Quantity by Type (2021-2032)
  • 8.2 Europe Tacrolimus Extended Release Capsules Sales Quantity by Application (2021-2032)
  • 8.3 Europe Tacrolimus Extended Release Capsules Market Size by Country
    • 8.3.1 Europe Tacrolimus Extended Release Capsules Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Tacrolimus Extended Release Capsules Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tacrolimus Extended Release Capsules Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Tacrolimus Extended Release Capsules Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Tacrolimus Extended Release Capsules Market Size by Region
    • 9.3.1 Asia-Pacific Tacrolimus Extended Release Capsules Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Tacrolimus Extended Release Capsules Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Tacrolimus Extended Release Capsules Sales Quantity by Type (2021-2032)
  • 10.2 South America Tacrolimus Extended Release Capsules Sales Quantity by Application (2021-2032)
  • 10.3 South America Tacrolimus Extended Release Capsules Market Size by Country
    • 10.3.1 South America Tacrolimus Extended Release Capsules Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Tacrolimus Extended Release Capsules Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tacrolimus Extended Release Capsules Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Tacrolimus Extended Release Capsules Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Tacrolimus Extended Release Capsules Market Size by Country
    • 11.3.1 Middle East & Africa Tacrolimus Extended Release Capsules Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Tacrolimus Extended Release Capsules Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Tacrolimus Extended Release Capsules Market Drivers
  • 12.2 Tacrolimus Extended Release Capsules Market Restraints
  • 12.3 Tacrolimus Extended Release Capsules Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tacrolimus Extended Release Capsules and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tacrolimus Extended Release Capsules
  • 13.3 Tacrolimus Extended Release Capsules Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tacrolimus Extended Release Capsules Typical Distributors
  • 14.3 Tacrolimus Extended Release Capsules Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tacrolimus Extended Release Capsules market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Tacrolimus Extended Release Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tacrolimus Extended Release Capsules market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Tacrolimus Extended Release Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Tacrolimus Extended Release Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Tacrolimus Extended Release Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tacrolimus Extended Release Capsules
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tacrolimus Extended Release Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas pharma Europe B.V., Mylan Pharmaceuticals, Sandoz, Accord Healthcare, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tacrolimus Extended Release Capsules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    0.5mg
    1mg
    5mg
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Astellas pharma Europe B.V.
    Mylan Pharmaceuticals
    Sandoz
    Accord Healthcare
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tacrolimus Extended Release Capsules product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tacrolimus Extended Release Capsules, with price, sales quantity, revenue, and global market share of Tacrolimus Extended Release Capsules from 2021 to 2026.
    Chapter 3, the Tacrolimus Extended Release Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tacrolimus Extended Release Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tacrolimus Extended Release Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tacrolimus Extended Release Capsules.
    Chapter 14 and 15, to describe Tacrolimus Extended Release Capsules sales channel, distributors, customers, research findings and conclusion.

    Buy now